Engineering patient-specific cancer immunotherapies L Scheetz, KS Park, Q Li, PR Lowenstein, MG Castro, A Schwendeman, ... Nature biomedical engineering 3 (10), 768-782, 2019 | 135 | 2019 |
Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy R Kuai, X Sun, W Yuan, LJ Ochyl, Y Xu, AH Najafabadi, L Scheetz, MZ Yu, ... Journal of controlled release 282, 131-139, 2018 | 116 | 2018 |
Sugar-nanocapsules imprinted with microbial molecular patterns for mRNA vaccination S Son, J Nam, I Zenkov, LJ Ochyl, Y Xu, L Scheetz, J Shi, OC Farokhzad, ... Nano letters 20 (3), 1499-1509, 2020 | 75 | 2020 |
Synthetic high-density lipoprotein nanodiscs for personalized immunotherapy against gliomas L Scheetz, P Kadiyala, X Sun, S Son, A Hassani Najafabadi, M Aikins, ... Clinical Cancer Research 26 (16), 4369-4380, 2020 | 58 | 2020 |
Cancer immunotherapy via targeting cancer stem cells using vaccine nanodiscs A Hassani Najafabadi, J Zhang, ME Aikins, ZI Najaf Abadi, F Liao, Y Qin, ... Nano letters 20 (10), 7783-7792, 2020 | 55 | 2020 |
Synthetic HDL nanoparticles delivering docetaxel and CpG for chemoimmunotherapy of colon adenocarcinoma LM Scheetz, M Yu, D Li, MG Castro, JJ Moon, A Schwendeman International journal of molecular sciences 21 (5), 1777, 2020 | 30 | 2020 |
Size-controlled iron oxide nanoplatforms with lipidoid-stabilized shells for efficient magnetic resonance imaging-trackable lymph node targeting and high-capacity biomolecule … RM Clauson, M Chen, LM Scheetz, B Berg, B Chertok ACS applied materials & interfaces 10 (24), 20281-20295, 2018 | 28 | 2018 |
Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development MB Garcia-Fabiani, M Ventosa, A Comba, M Candolfi, AJ Nicola Candia, ... Expert Opinion on Investigational Drugs 29 (7), 659-684, 2020 | 17 | 2020 |
Robust anti‐tumor T cell response with efficient Intratumoral infiltration by nanodisc cancer immunotherapy R Kuai, PB Singh, X Sun, C Xu, A Hassani Najafabadi, L Scheetz, W Yuan, ... Advanced therapeutics 3 (9), 2000094, 2020 | 13 | 2020 |
Immunoactive dna-tethered nanocomplexes of antigen-cpg and iron-oxide nanoparticles as potential cancer nanovaccines RM Clauson, L Scheetz, B Berg, B Chertok Frontiers in Bioengineering and Biotechnology, 0 | 1 | |
Personalized Cancer Vaccine Development for Brain and Colon Cancers Using Synthetic HDL Nanoparticles L Scheetz | | 2020 |
In Vivo Evaluation of CD8+ T Cell Immune Response to Iron Oxide-Based Nanovaccine L Scheetz, R Clauson, B Chertok 2017 Controlled Release Society Annual Meeting, 2017 | | 2017 |
MRI-Visible Subunit Vaccine Nanoplatform for Lymph Node Delivery and CD8+ T-cell Activation R Clauson, L Scheetz, M Chen, B Berg, B Chertok 2017 Controlled Release Society Annual Meeting, 2017 | | 2017 |